Recent findings suggest that the GluN2A subunit of NMDA receptors mediates these antidepressant effects [36], whereas loss-of-function mutations in this subunit significantly increase susceptibility to schizophrenia [39, 40]. This evidence concerns the gene GRIN2A and schizophrenia.